TradingView
JetEquities
3 de Jun de 2019 16:55

Emergent BioSolutions Awarded 10-Year HHS Contract Valued at App Viés de alta

NYSE:EBS30
Emergent Biosolutions, Inc.NYSE

Descrição

⋅
EBS: Emergent BioSolutions
2019-06-03 06:30:00
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness - GlobeNewswire
Beyond Technical Analysis
Mais